New drug QRX3 could slow kidney decline in millions
NCT ID NCT06866236
First seen Nov 01, 2025 · Last updated May 10, 2026 · Updated 29 times
Summary
This study tests a new drug called QRX3 in 3000 people with chronic kidney disease (CKD) whose kidney function is declining. The goal is to see if QRX3 can improve kidney function and slow further damage. Participants will take the drug and have their kidney function measured over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Neukidney Inc
Pasedena, Texas, 77504, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.